| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 254 | 259 | 655 | 971 | | Cost of Revenue |
-
| (1,759) | 487 | 1,272 | | | Gross Profit | 254 | 2,018 | 169 | (301) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 935 | 3,097 | 627 | 189 | | Non Recurring |
-
| 10 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (847) | (1,090) | (458) | (491) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,127) | (1,642) | (150) | (551) | | Earnings Before Interest And Taxes | (2,808) | (2,731) | (609) | (1,041) | | Interest Expense | 166 | 176 | 161 | 266 | | Income Before Tax | (2,974) | (2,907) | (770) | (1,307) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,974) | (2,907) | (770) | (1,307) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,974) | (2,907) | (770) | (1,307) | | Preferred Stock And Other Adjustments |
-
|
-
| (84) | (84) | | | Net Income Applicable To Common Shares | ($2,974) | ($2,907) | ($854) | ($1,392) |
|
0.26% Nasdaq 
Income Statement
